Episurf Medical AB (publ)
The answer first
Does Episurf Medical beat the market?
Yes, Episurf Medical has beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 40% of Nordic stocks
- Quality53
- Value57
- Trend31
No. 81 of 195 in healthcare
Expectations in the price
High expectations
For the share to return about 9% a year from today's price, the cash Episurf Medical keeps must grow about 21% a year for 10 years.
Max for seven days
Follow Episurf Medical with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 20 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Episurf Medical
Your first answer is free, no account needed.
Do you own Episurf Medical, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Episurf Medical and a few more. Free, no card.
Super Stock+46.4%In short
- Episurf Medical has risen 72.9% over the past year, including dividends.
- Overall, Episurf Medical ranks better than 40% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 97.9%. The price is 99.7% below its peak now.
What do analysts think of Episurf Medical?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 40% of Nordic stocks.
No. 81 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 121 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.01
- Asset turnoverSales divided by everything the company owns0.01
- Return on equityProfit divided by equity−43.1%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Medium Fair price: about the same as a typical Nordic stock.
No. 39 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity0.4
- P/SPrice divided by sales10.7
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flow45.1
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 106 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−38.2%
- 6 months−73.7%
- 9 months+42.1%
- 12 months+72.9%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own Episurf Medical
3 funds we follow own Episurf Medical. The share is how much of the fund the stock makes up.
- Sweden3
From the funds' latest known holdings.
About Episurf Medical
Episurf Medical AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. By market value, Episurf Medical is number 65 of 137 companies in healthcare on Nasdaq Stockholm. Episurf Medical has not paid a dividend in the past twelve months. Of the three measures in the ranking, Episurf Medical is strongest on value, better than 57% of Nordic stocks. The share trades in SEK. It has around 22 employees.
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It provides Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint.


See the full analysis of Episurf Medical.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card